{"id":"tp-57025","type":"article-newspaper","title":"FDA Approves Perioperative Durvalumab-Padcev for Cisplatin-Ineligible MIBC","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/57025","datePublished":"2026-11-13T21:33:17.000Z","dateModified":"2026-11-13T21:33:17.000Z","language":"en","abstract":"The approval covers perioperative use in patients who cannot receive cisplatin-based chemotherapy.","section":"Regulation","references":[]}